Well, if you are like the majority of us, thats easier said than done and doesnt always work
The dedicated FLOW trial of subcutaneous semaglutide in T2D-related CKD showed a 24% reduction in the composite of major kidney disease events (HR 0.76, 95% CI 0.660.88) and significant reductions in cardiovascular outcomes [22], supporting GLP-1RA therapy as an evidence-based addition for cardiorenal protection in this population
Thats important because weight gain isnt simply about willpower, its influenced by hormones that regulate hunger and fullness
In clinical trials of Wegovy (a semaglutide medication), participants lost an average of 15% of their body weight (approximately 33 pounds, though individual results varied) within 68 weeks
Diabetes Obes Metab (2017) 19:33647
Ideally, keep it as close to your regular seven-day interval as possible